InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Tempest Therapeutics, Inc.

TPST Clue Score26
United States Fiscal year ends December CIK 0001544227
$0.74 -2.29% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.74 −95.10% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.7Operating income−81.0Net income−82.3Fiscal year 2017Revenue0.3 −54.8%Operating income−84.3Net income−84.6Fiscal year 2018Operating income−26.9Net income−27.2Fiscal year 2019Operating income−45.4Net income−44.6Fiscal year 2020Operating income−19.3Net income−19.2EPS, diluted−41.03Fiscal year 2021Operating income−27.0Net income−28.3EPS, diluted−7.47Fiscal year 2022Operating income−34.6Net income−35.7EPS, diluted−3.09Fiscal year 2023Operating income−29.2Net income−29.5EPS, diluted−1.91Fiscal year 2024Operating income−42.0Net income−41.8EPS, diluted−19.50Fiscal year 2025Operating income−26.6Net income−26.3EPS, diluted−6.33
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.7 0.3 n/a n/a n/a n/a n/a n/a n/a n/a
Growth −54.8%
Operating income −81.0 −84.3 −26.9 −45.4 −19.3 −27.0 −34.6 −29.2 −42.0 −26.6
Net income −82.3 −84.6 −27.2 −44.6 −19.2 −28.3 −35.7 −29.5 −41.8 −26.3
Growth
EPS, diluted n/a n/a n/a n/a −41.03 −7.47 −3.09 −1.91 −19.50 −6.33

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−12,406.1%Net margin−12,597.2%Free cash flow margin−9,849.9%Fiscal year 2017Operating margin−28,585.1%Net margin−28,670.5%Free cash flow margin−6,896.3%Fiscal year 2018Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −12,406.1% −28,585.1% n/a n/a n/a n/a n/a n/a n/a n/a
Net margin −12,597.2% −28,670.5% n/a n/a n/a n/a n/a n/a n/a n/a
Free cash flow margin −9,849.9% −6,896.3% n/a n/a n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−61.7Capital expenditure−2.6Free cash flow−64.3Fiscal year 2017Operating cash flow−20.3Capital expenditure−0.0Free cash flow−20.3Fiscal year 2018Operating cash flow−23.6Capital expenditure−0.0Free cash flow−23.7Fiscal year 2019Operating cash flow−41.2Capital expenditure−0.4Free cash flow−41.6Fiscal year 2020Operating cash flow−19.0Capital expenditure−0.1Free cash flow−19.1Fiscal year 2021Operating cash flow−26.0Capital expenditure−0.1Free cash flow−26.1Fiscal year 2022Operating cash flow−31.1Capital expenditure−0.6Free cash flow−31.6Fiscal year 2023Operating cash flow−27.4Capital expenditure−0.2Free cash flow−27.5Fiscal year 2024Operating cash flow−33.0Capital expenditure−0.4Free cash flow−33.5Fiscal year 2025Operating cash flow−26.8Capital expenditure0.0Free cash flow−26.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −61.7 −20.3 −23.6 −41.2 −19.0 −26.0 −31.1 −27.4 −33.0 −26.8
Capital expenditure −2.6 −0.0 −0.0 −0.4 −0.1 −0.1 −0.6 −0.2 −0.4 0.0
Free cash flow −64.3 −20.3 −23.7 −41.6 −19.1 −26.1 −31.6 −27.5 −33.5 −26.8
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash43.9Shareholders’ equity108.2Fiscal year 2017Cash17.6Total debt0.6Net cash (debt)17.0Shareholders’ equity−130.7Fiscal year 2018Cash73.3Total debt0.6Net cash (debt)72.7Shareholders’ equity71.0Debt to equity0.01Fiscal year 2019Cash62.5Total debt0.4Net cash (debt)62.1Shareholders’ equity−50.4Fiscal year 2020Cash18.8Total debt0.3Net cash (debt)18.5Shareholders’ equity−68.8Fiscal year 2021Cash51.8Total debt15.1Net cash (debt)36.8Shareholders’ equity36.1Debt to equity0.42Fiscal year 2022Cash31.2Total debt10.4Net cash (debt)20.9Shareholders’ equity18.1Debt to equity0.57Fiscal year 2023Cash39.2Total debt10.5Net cash (debt)28.7Shareholders’ equity26.8Debt to equity0.39Fiscal year 2024Cash30.3Total debt6.4Net cash (debt)23.9Shareholders’ equity19.1Debt to equity0.33Fiscal year 2025Cash7.7Total debt0.0Net cash (debt)7.7Shareholders’ equity6.7Debt to equity0.00
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 43.9 17.6 73.3 62.5 18.8 51.8 31.2 39.2 30.3 7.7
Total debt n/a 0.6 0.6 0.4 0.3 15.1 10.4 10.5 6.4 0.0
Net cash (debt) n/a 17.0 72.7 62.1 18.5 36.8 20.9 28.7 23.9 7.7
Shareholders’ equity 108.2 −130.7 71.0 −50.4 −68.8 36.1 18.1 26.8 19.1 6.7
Debt to equity n/a n/a 0.01 n/a n/a 0.42 0.57 0.39 0.33 0.00

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
0.7 0.3 n/a n/a n/a n/a n/a n/a n/a n/a
Growth −54.8%
5.4 0.8 n/a n/a n/a n/a n/a n/a n/a n/a
21.6 18.3 n/a n/a n/a n/a n/a n/a n/a n/a
49.2 27.7 8.7 17.6 4.9 9.8 12.1 11.7 13.6 14.0
−81.0 −84.3 −26.9 −45.4 −19.3 −27.0 −34.6 −29.2 −42.0 −26.6
Growth
−82.1 −50.9 n/a n/a n/a n/a n/a n/a n/a n/a
0.2 0.1 n/a n/a 0.0 0.0 0.0 0.0 0.0 0.0
−82.3 −84.6 −27.2 −44.6 −19.2 −28.3 −35.7 −29.5 −41.8 −26.3
Growth
Per share
n/a n/a n/a n/a −41.03 −7.47 −3.09 −1.91 −19.50 −6.33
n/a n/a n/a n/a −41.03 −7.47 −3.09 −1.91 −19.50 −6.33
Growth
n/a n/a n/a n/a 0.5 3.8 11.5 15.4 2.1 4.1
n/a n/a n/a n/a 0.5 3.8 11.5 15.4 2.1 4.1
Growth +709.6% +204.7% +33.5% −86.1% +93.3%

† The diluted share count jumps at 2021 and 2022 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 10 of 10 years on file.